Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
8261
Macroeconomic burden of NMHs for the whole South American region over the period 2020–2050 across various scenarios.
Published 2023“…<i>Larger treatment cost impact scenario</i> = treatment costs reduce physical capital investments by a proportion 50% greater than the saving rate; all other assumptions as in the baseline scenario. …”
-
8262
Reduction of branchiovisceral motor neurons in rhombomere 7 of the Nkx2.2; Nkx2.9 double-null mutant mouse embryo.
Published 2015“…Scale bar in E represents 50 μm and applies to all figure panels.</p>…”
-
8263
Dys regulates <i>rpr</i> expression and apoptosis.
Published 2014“…Asterisk marks the tip of the leg where endogenous high levels of DCas-3 are observed. (E–F) Close sagittal view of one tarsal joint in a wild type (E) and <i>dys<sup>2</sup>/dys<sup>3</sup></i> mutant prepupal legs where the domains of <i>E(spl)mβ-CD2</i> (red) and the “fold” domain (between the two <i>E(spl)mβ-CD2</i>) are visible. …”
-
8264
Lead Optimization of Androgen Receptor-HSP27 Disrupting Agents in Glioblastoma
Published 2023“…Compounds <b>4</b> and <b>6</b> exhibit IC<sub>50</sub>s of 35 and 23 nM, respectively, to inhibit cell proliferation and also show significant activity to decrease the tumor growth <i>in vivo</i>.…”
-
8265
-
8266
-
8267
Depletion of TPX2 causes defects in 53BP1 ionizing radiation-induced foci formation.
Published 2014“…<p>(A) The protein level of 53BP1 is not affected by miRNA-mediated depletion of TPX2. …”
-
8268
-
8269
Management of Recurrent Bronchopleural Fistula: A Multidisciplinary Approach for A Reconstructive Challenge
Published 2022“…<p> </p> <p>Urgent pneumonectomy for benign disease is rare but highly morbid, with a perioperative mortality approaching 50 percent. …”
-
8270
Sample means, SDs, and selected correlations.
Published 2025“…Educational attainment was a particularly strong predictor of status attainment. …”
-
8271
-
8272
-
8273
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice
Published 2022“…Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …”
-
8274
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in Mice
Published 2022“…Toward validating this receptor as a target in SCI, we have developed a new series of LPA<sub>2</sub> antagonists, among which compound <b>54</b> (UCM-14216) stands out as a potent and selective LPA<sub>2</sub> receptor antagonist (<i>E</i><sub>max</sub> = 90%, IC<sub>50</sub> = 1.9 μM, <i>K</i><sub>D</sub> = 1.3 nM; inactive at LPA<sub>1,3–6</sub> receptors). …”
-
8275
Image_1_The P2X7 Receptor 489C>T Gain of Function Polymorphism Favors HHV-6A Infection and Associates With Female Idiopathic Infertility.tif
Published 2020“…We show that functional P2X7R increases while its blockade decreases viral load. …”
-
8276
Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis
Published 2025“…<b>19c</b> markedly reduced fibrotic deposition, with a decrease in fibrosis stage and area in the CCl<sub>4</sub>-induced liver fibrosis mouse model. …”
-
8277
Synthesis and Biological Evaluation of Peripheral 5HT<sub>2B</sub> Antagonists for Liver Fibrosis
Published 2025“…<b>19c</b> markedly reduced fibrotic deposition, with a decrease in fibrosis stage and area in the CCl<sub>4</sub>-induced liver fibrosis mouse model. …”
-
8278
NADPH oxidation and H<sub>2</sub>O<sub>2</sub> production by Bs3 and Bs3<sub>S211A</sub>.
Published 2021“…NADPH oxidation was monitored via decrease of absorbance at 340 nm. Yucasin and methimazole (MMI) were dissolved in DMSO and added at a final concentration of 50 μM. …”
-
8279
The effect of glibenclamide on channel activity at +20, 0 and -20 mV.
Published 2015“…Histogram bars show current amplitudes and P<sub>o</sub> of reconstituted channels in absence or presence of glibenclamide. The addition of 50 μM glibenclamide resulted in a decreased current jump amplitude and a reduction in P<sub>o</sub>. 100 μM glibenclamide caused a total channel inhibition at +20 and 0 mV (n = 5), but was ineffective at -20 mV. …”
-
8280
Image_3_DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation.tif
Published 2022“…By data mining with publicly accessible cancer genomics databases and a clinical genomic database from a tertiary medical institution, DNMT3A R882 mutations were found to be enriched in AML (53% of all DNMT3A mutations) but decreased in frequency in clonal hematopoiesis of indeterminate potential (CHIP) (10.6%) or other myeloid neoplasms including MDS (27%) (p<.001). …”